Your browser doesn't support javascript.
loading
The effect of AB0 and Rhesus blood grouping systems on oncological outcome in patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma.
Rink, Michael; Engel, Oliver; Gakis, Georgios; Fritsche, Hans Martin; Vetterlein, Malte W; Soave, Armin; Peine, Sven; Aziz, Atiqullah; Dahlem, Roland; Stenzl, Arnulf; Burger, Maximilian; Shariat, Shahrokh F; Fisch, Margit; Gild, Philipp.
Afiliación
  • Rink M; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Electronic address: m.rink@uke.de.
  • Engel O; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Gakis G; Department of Urology, University Hospital Tübingen, Tübingen, Germany.
  • Fritsche HM; Department of Urology, Caritas St. Josef Medical Centre, University of Regensburg, Regensburg, Germany.
  • Vetterlein MW; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Soave A; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Peine S; Institute of Transfusion Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Aziz A; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, Caritas St. Josef Medical Centre, University of Regensburg, Regensburg, Germany; Department of Urology, University of Rostock, Rostock, Germany.
  • Dahlem R; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Stenzl A; Department of Urology, University Hospital Tübingen, Tübingen, Germany.
  • Burger M; Department of Urology, Caritas St. Josef Medical Centre, University of Regensburg, Regensburg, Germany.
  • Shariat SF; Department of Urology, Medical University of Vienna, Vienna, Austria.
  • Fisch M; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Gild P; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Urol Oncol ; 35(12): 671.e17-671.e23, 2017 12.
Article en En | MEDLINE | ID: mdl-28889922
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tipificación y Pruebas Cruzadas Sanguíneas / Carcinoma de Células Transicionales / Neoplasias Urológicas / Nefroureterectomía Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Urol Oncol Asunto de la revista: NEOPLASIAS / UROLOGIA Año: 2017 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tipificación y Pruebas Cruzadas Sanguíneas / Carcinoma de Células Transicionales / Neoplasias Urológicas / Nefroureterectomía Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Urol Oncol Asunto de la revista: NEOPLASIAS / UROLOGIA Año: 2017 Tipo del documento: Article